OTCMKTS:MYMX Mymetics (MYMX) Stock Price, News & Analysis $0.0010 0.00 (0.00%) (As of 09/13/2024 ET) Add Compare Share Share Today's Range$0.0010▼$0.001050-Day Range N/A52-Week Range$0.0010▼$0.0010VolumeN/AAverage Volume1 shsMarket Capitalization$152.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Mymetics alerts: Email Address Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. About MymeticsMymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.Read More MYMX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYMX Stock News HeadlinesMarch 29, 2024 | seekingalpha.comPLTXF PlantX Life Inc.February 2, 2024 | finance.yahoo.comMymetics Corporation (MYMXD) Stock Historical Prices & Data - Yahoo FinanceSeptember 16, 2024 | Brownstone Research (Ad) My big AI project…On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.December 31, 2023 | benzinga.comMymetics Stock (OTC:MYMX) Dividends: History, Yield and DatesMarch 1, 2023 | lse.co.ukOriole Resources project in Cameroon delivers high-grade gold resultsNovember 16, 2022 | benzinga.comMymetics Stock (OTC:MYMX), Short Interest ReportOctober 11, 2022 | finance.yahoo.comMymetics Corporation (MYMX)September 1, 2022 | seekingalpha.comMymetics, PCI Biotech team up for preclinical research on cancer therapySeptember 16, 2024 | InvestorPlace (Ad)44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. But now a looming disaster is threatening America. And it's unlike anything we've ever experienced before.September 1, 2022 | finanznachrichten.deMymetics Corporation: Mymetics and PCI Biotech Sign a Preclinical Research CollaborationAugust 31, 2022 | finance.yahoo.comMymetics and PCI Biotech Sign a Preclinical Research CollaborationAugust 25, 2022 | reuters.comMYMX.PK - Mymetics Corp | Stock Price & Latest News | ReutersSee More Headlines Receive MYMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:MYMX CUSIPN/A CIK927761 Webwww.mymetics.com Phone(121) 653-4535Fax41-21-653-2473Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.08 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.23) per share Price / Book0.00Miscellaneous Outstanding Shares152,000Free Float144,000Market Cap$152.00 OptionableNot Optionable Beta1.64 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Ronald Kempers (Age 56)CEO, COO, President & CFO Comp: $303.83kMr. Mario Amacker Ph.D.Head of Quality & ManufacturingKey Competitors180 Life SciencesNASDAQ:ATNFW4D pharmaNASDAQ:LBPSW4Front VenturesOTCMKTS:FFNTFAbattis BioceuticalsOTCMKTS:ATTBFAeolus PharmaceuticalsOTCMKTS:AOLSView All Competitors MYMX Stock Analysis - Frequently Asked Questions How have MYMX shares performed this year? Mymetics' stock was trading at $0.0020 on January 1st, 2024. Since then, MYMX shares have decreased by 50.0% and is now trading at $0.0010. View the best growth stocks for 2024 here. How do I buy shares of Mymetics? Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Mymetics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mymetics investors own include Genocea Biosciences (GNCA), Dynavax Technologies (DVAX), Fujitsu (FJTSY), Himax Technologies (HIMX), Maxar Technologies (MAXR), Revance Therapeutics (RVNC) and Boeing (BA). This page (OTCMKTS:MYMX) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mymetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mymetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.